首页> 外文期刊>Archivio Italiano di Urologia e Andrologia >First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection
【24h】

First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection

机译:首例18F-FACBC PET / CT引导的抢救性放疗用于根治性前列腺切除术后局部复发且11C-胆碱PET / CT阴性和多参数MRI:新的成像技术可改善患者选择

获取原文
           

摘要

We present the first case of salvage radiotherapy based on the results of 18F-FACBC PET/CT performed for a PSA relapse after radical prostatectomy. The patients underwent 11CCholine PET/CT and multiparametric MRI that were negative while 18F-FACBC PET/CT visualized a suspected local relapse confirmed by transrectal ultrasound-guided biopsy. No distant relapse was detected. Thus the patient was submitted to salvage radiotherapy in the prostatic fossa. After 20 months of follow-up, the PSA was undetectable and 18F-FACBC PET/CT was negative. Salvage radiotherapy after surgery, provided that it is administered at the earliest evidence of the biochemical relapse, may improve cancer control and favourably influence the course of disease as well as the adjuvant approach. New imaging techniques may increase the efficacy of the salvage radiotherapy thus helping in the selection of the patients. Preliminary clinical reports showed an improvement in the detection rate of 20-40% of 18F-FACBC in comparison with 11C-Choline for the detection of disease relapse after radical prostatecomy, rendering the 18F-FACBC the potential radiotracer of the future for prostate cancer.
机译:我们根据根治性前列腺切除术后PSA复发的18F-FACBC PET / CT结果,提出了第一例抢救性放疗。患者接受了11CCholine PET / CT和多参数MRI阴性,而18F-FACBC PET / CT则通过经直肠超声引导的活检证实了可疑的局部复发。未检测到远处复发。因此,患者在前列腺窝进行了放疗。随访20个月后,PSA未检出,而18F-FACBC PET / CT阴性。手术后的挽救性放疗,只要在生化复发的最早证据下进行,可能会改善癌症的控制,并有利地影响疾病的进程以及辅助治疗方法。新的成像技术可能会提高挽救性放疗的功效,从而有助于选择患者。初步临床报告显示,与11C-胆碱相比,18F-FACBC在根治性前列腺癌术后疾病复发中的检出率提高了20-40%,这使18F-FACBC成为未来前列腺癌的潜在放射性示踪剂。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号